1.Clinical observation of S-1 plus oxaliplatin in the treatment of locally advanced or metastatic colorectal cancer
Mei ZHU ; Yanhua ZHANG ; Weiyan GAO ; Hongxia HUANG ; Lige YAO ; Tiandong KONG
Cancer Research and Clinic 2014;26(12):820-822
Objective To evaluate the efficacy and safety profile of S-1 combined with oxaliplatin L-OHP (SOX) in the treatment of locally advanced or metastatic colorectal cancer.Methods 70 patients with advanced or metastatic colorectal cancer were randomly divided into trial group (35 cases) and control group (35 cases).The trail group was administered with dose of 130 mg/m2 L-OHP,plus S-1 which was given orally with body surface area (BSA) (BSA<1.25 m2,80 mg/d; BSA≥ 1.25 m2 and <1.5 m2,100 mg/d; BSA≥ 1.50 m2 and <1.8 m2,120 mg/d; BSA>1.8 m2,140 mg/d).This schedule was repeated every 3 weeks.The control group treated by FOLFOX4 regimen (L-OHP was given on d1 with 80 mg/m2 through intravenous,leucovorin was intravenously on d1,2,with 200 mg/m2,5-Fu was intravenously injected on d1,2,with 400 mg/m2,and was administered intravenously 44 hours with 1 200 mg/m2 on d1).This schedule was repeated every 2 weeks.Results The total clinical effective rate had no significant difference in the trail group and control group (51.4 %,18/35 vs 45.7 %,16/35) (x2 =0.229,P =0.632).Toxicity,nausea and vomiting rate in the trail group were lower than those in the control group (48.5 %,16/35 vs 71.4 %,25/35,68.6 %,24/35 vs 88.6 %,31/35,P < 0.05),but hand-foot syndrome and peripheral neurotoxicity rates had no significant difference between two groups (P > 0.05).Weight increased significantly after chemotherapy treatment in the two groups (t =2.702 5,P =0.003 9).Conclusion SOX regimen is feasible and safe for advanced colorectal cancer.
2.Changes and significance of serum Klotho protein levels in different stages of chronic kidney disease
Aiqin LIU ; Lei YU ; Lige ZHU ; Deyu ZHANG ; Jiling MA
Clinical Medicine of China 2019;35(6):536-540
Objective To explore the changes and significance of Klotho protein levels in different stages of chronic kidney disease (CKD). Methods From March 2015 to December 2017,176 patients with CKD admitted to nephrology department of Inner Mongolia People's Hospital were selected as the study object (CKD group), and 80 healthy patients in our hospital were selected as the control group in the same period. The serum Klotho levels of CKD patients and control group at different stages were detected by double antibody sandwich ELISA, and the differences between each group were compared. Results The serum Klotho level of CKD group (( 4. 84 ± 1. 87) μg/L) was significantly lower than that of the control group ((9. 11± 3. 14) μg/L) ( t= 13. 82, P<0. 01) . One-way anova showed that estimated renal glomerular filtration rate (eGFR),serum albumin (ALB),hemoglobin ( Hb),blood calcium ( Ca) and serum Klotho were gradually decreased,while phosphorus (P) and creatinine (Cr) in serum were gradually increased,and the difference was statistically significant among the five stages( all P<0. 01). Spearman correlation analysis showed that Klotho level was positively correlated with eGFR and Ca,and negatively correlated with CKD stage,Cr and P (r=0. 369,0. 160,-0. 200,-0. 250,-0. 230,all P<0. 05). The multiple linear regression equation showed that Klotho level was positively and independently correlated with eGFR ( t= 3. 89, P<0. 001),and negatively correlated with CKD staging independently (t=-4. 12,P<0. 001). Conclusion The expression level of serum Klotho protein in patients with CKD is lower than that of healthy people,and it decreases with the increase of CKD stages,which is closely related to the deterioration of renal function. It can be used as a reference index to evaluate the incidence and severity of CKD.
3.Determination of prim-O-glucosylcimifugin and 5-O-methylvisammisoide in Saposhnikovia divaricata and HPLC fingerprint analysis.
Lijie MA ; Bin YANG ; Xuefeng FENG ; Xiaojie YIN ; Hua LI ; Xiaoguang GE ; Lige ZHU ; Jun CAO
China Journal of Chinese Materia Medica 2010;35(13):1731-1734
OBJECTIVETo develop HPLC methods for the determination of prim-O-glucosylcimifugin and 5-O-methylvisammisoide in Saposhnicovia divaricata and of HPLC fingerprint to compare the wild and culture varieties.
METHODConditions of determination: Shimadzu C18 column (4.6 mm x 150 mm, 5 microm), methanol-water (40:60) as mobile phase with the flow rate of 1 mL x min(-1). The detection wavelength was 254 nm. Conditions of HPLC fingerprint: MG II C18 column (4.6 mm x 250 mm, 5 microm), the mobile phase was acetonitrile-water with the flow rate of 1 mL x min(-1), using linear gradient elution, the column temperature was 30 degrees C.
RESULTThe average recovery of prim-O-glucosylcimifugin was 99.6% (RSD 0.72%, n=6). The average recovery of 5-O-methylvisammisoide was 102.6% (RSD 0.88%, n=6). The contents of prim-o-glucosylcimifugin in wild and culture varieties were (4.96 +/- 2.59) and (3.61 +/- 1.82) mg x g(-1) respectively. The contents of 5-O-methylvisammisoide were (3.91 +/- 2.09) and (4.37 +/- 2.02) mg x g(-1) respectively. The compositions of S. divaricata were effective separated under the conditions of HPLC fingerprint.
CONCLUSIONThe HPLC determination method of prim-O-glucosylcimifugin and 5-O-methylvisammisoide is convenient and accurate. The HPLC fingerprint analysis method could be a basis for quality control and classification evaluate of S. divaricata.
Apiaceae ; chemistry ; Chromatography, High Pressure Liquid ; methods ; Drugs, Chinese Herbal ; analysis ; isolation & purification ; Monosaccharides ; analysis ; isolation & purification ; Quality Control ; Xanthenes ; analysis ; isolation & purification